false
Hamburger Menu
Catalog
Targeting RET in NSCLC
Targeting RET in NSCLC
Podcast | English | 2021 | 32 Min
Create Account
Credit
No Credit Offered
Summary
The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.
Faculty
Dr. Stephen Liu
Dr. Alex Drilon
×
Targeting RET in NSCLC Course List
Login
User Login
Continue with Google
OR
Email
Password
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English